Laboratory Diagnosis and Susceptibility Testing for Mycobacterium tuberculosis

Area of Science:

• Clinical microbiology
• Molecular diagnostics
• Mycobacteriology

Background:

• The clinical laboratory is crucial for tuberculosis diagnosis, employing advanced technologies.
• Sophisticated diagnostic tools are increasingly used in resource-limited settings for Mycobacterium tuberculosis detection.
• Accurate specimen criteria are essential for optimal laboratory test performance.

Purpose of the Study:

• To review current and emerging laboratory technologies for tuberculosis diagnosis.
• To highlight the role of molecular methods in detecting Mycobacterium tuberculosis and drug resistance.
• To discuss advancements in isolate identification and susceptibility testing.

Main Methods:

• Acid-fast staining and rapid-cycle PCR for direct specimen detection.
• Xpert MTB/RIF assay for simultaneous detection of M. tuberculosis and rifampin resistance.
• Culture-based methods (broth and solid media) for diagnosis and identification using biochemical profiling, molecular methods (DNA probes, PCR, sequencing), HPLC, and MALDI-TOF MS.
• Susceptibility testing (broth-based recommended) and strain typing.
• Next-generation sequencing (NGS) for comprehensive analysis.

Main Results:

• Molecular methods are replacing traditional staining for direct detection.
• Xpert MTB/RIF assay facilitates early detection of multidrug-resistant tuberculosis.
• Molecular identification and broth-based susceptibility testing offer faster results.
• NGS provides simultaneous identification, susceptibility, and typing information.

Conclusions:

• Laboratory diagnostics for tuberculosis are rapidly evolving, driven by molecular technologies.
• Advanced techniques improve the speed and accuracy of diagnosing tuberculosis and drug resistance.
• Next-generation sequencing represents a significant advancement in mycobacteriology.